ARCHIVES

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

DCCP Payback System Saving $1 Million Year

December 3, 1982

FDA To Regulate Products From Human Cells, Tissue

March 21, 1997

ACS Funds Pilot Study Of Mammography Trial

July 28, 1995

Largest Oncological Society Exerts Clout, Getting Results

June 24, 1983

Clearinghouse Members Names, First Meeting Scheduled For Nov. 8-9

September 24, 1976

Funding Opportunities

January 24, 2003